CORRECTED: Informax s Titomirov Launches Preventive-Technology Start-Up | GenomeWeb

This story has been corrected from a previous version, which incorrectly stated that Ronald Kahn was a co-founder of RealTime Health. He is on the company's scientific advisory board. 

BETHESDA, Md., Dec 4 – InforMax CEO Alex Titomirov said Tuesday he was launching a new start-up that would make gene expression-based preventive medicine technology available to individuals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.